BIND Therapeutics
101 Binney Street
Cambridge
Massachusetts
02142
United States
Tel: 617-491-3400
Fax: 617-491-0351
Website: http://www.bindbio.com/
Email: info@bindbio.com
133 articles about BIND Therapeutics
-
BIND Therapeutics Promotes Key Executives: Organization Positioned For Continued Growth
3/4/2014
-
BIND Therapeutics To Present At 26th Annual Roth Conference
2/26/2014
-
BIND Therapeutics To Present At Cowen and Company 34th Annual Healthcare Conference
2/24/2014
-
BIND Therapeutics To Present At February Healthcare Conferences
1/28/2014
-
BIND Therapeutics To Be Added To Russell Indexes On December 20, 2013
12/20/2013
-
BIND Therapeutics And Amgen Amend Collaboration Agreement For Kinase Inhibitor Nanomedicine
12/13/2013
-
BIND Therapeutics Co-Founders Demonstrate Ability To Cross Biological Barriers With Targeted Therapeutic Nanoparticles
12/2/2013
-
BIND Therapeutics Reports Third Quarter 2013 Financial Results
11/5/2013
-
BIND Therapeutics to Present at the Credit Suisse 2013 Healthcare Conference
11/4/2013
-
BIND Therapeutics Awarded the RUSNANOPRIZE 2013 for Innovative Development of Nanomedicine
11/4/2013
-
BIND Therapeutics to Report Third Quarter 2013 Financial Results and Business Developments on November 5, 2013
10/29/2013
-
BIND Therapeutics Announces Closing of Initial Public Offering
9/26/2013
-
BIND Therapeutics Scrounges Up $70.5 Million in IPO
9/20/2013
-
BIND Therapeutics Recognized by the World Economic Forum as a Technology Pioneer
8/27/2013
-
BIND Therapeutics Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Prostate Cancer
8/19/2013
-
BIND Therapeutics Files for $80.5 Million IPO
8/13/2013
-
BIND Therapeutics Doses First Patient in a Phase 2 Clinical Study of BIND-014 in Non-small Cell Lung Cancer
7/29/2013
-
BIND Therapeutics to Present at the UBS Global Healthcare Conference
5/6/2013
-
AstraZeneca PLC Signs $200 Million Deal With BIND Therapeutics for Cancer Drug
4/23/2013
-
BIND Therapeutics to Present at the Needham and Company 12th Annual Healthcare Conference
4/22/2013